On May 3, 2024, CytoDyn Inc. closed the transaction. The company has issued 42,300,000 units at a purchase price of $0.17 for gross proceeds of $ 7,191,000 in its second tranche, together a total of 52,600,000 units issued for $8,942,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1488 USD | +2.50% |
|
+9.25% | -23.69% |
27/06 | CytoDyn Inc. and SMC Laboratories, Inc. Announce Start of Preclinical MASH Study | CI |
30/05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-23.69% | 154M | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. announced that it has received $8.942 million in funding